Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversies concerning calcium antagonists

P R Lichtlen

    Cardiovascular Drugs and Therapy
    |September 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Controversial findings on calcium channel blockers (CCBs) safety, particularly nifedipine, are debated. Re-analyses suggest no significant mortality difference, but further studies on long-acting CCBs are needed.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    History of coronary heart disease.

    Zeitschrift fur Kardiologie·2002
    Same author

    Unstable angina in 1998.

    Thrombosis and haemostasis·2000
    Same author

    Analysis of arrhythmias in the Circadian Antiischemia Program in Europe (CAPE) study.

    Journal of cardiovascular pharmacology·1999
    Same author

    Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart.

    Journal of cardiovascular electrophysiology·1998
    Same author

    [Ambulatory coronary angiography and PTCA].

    Herz·1998
    Same author

    Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.

    Journal of the American College of Cardiology·1997
    Same journal

    Sennoside A Ameliorates Myocardial Fibrosis After Myocardial Infarction by Binding to KDM4B and Regulates IRX2 Expression.

    Cardiovascular drugs and therapy·2026
    Same journal

    Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis.

    Cardiovascular drugs and therapy·2026
    Same journal

    GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease.

    Cardiovascular drugs and therapy·2026
    Same journal

    Methodological Considerations in Evaluating Plaque Stabilization in Patients with High Lipoprotein(a).

    Cardiovascular drugs and therapy·2026
    Same journal

    Association of In-Hospital Dapagliflozin Initiation with Favorable left Ventricular Remodeling in Patients with Acute Myocardial Infarction and Heart Failure: A Retrospective Cohort Study.

    Cardiovascular drugs and therapy·2026
    Same journal

    Impact of Nitric Oxide Metabolites On Early Perioperative Biochemical Changes and Postoperative Complications in High-BMI Patients Undergoing On-Pump CABG: an Exploratory Observational Cohort Study.

    Cardiovascular drugs and therapy·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Controversy surrounds the safety of calcium channel blockers (CCBs), specifically dihydropyridine nifedipine.
    • Meta-analyses by Furberg et al. suggested detrimental effects, particularly during acute myocardial infarction.